Trial Profile
Anti-TNF-alpha (infliximab) in complex regional pain syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2010
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- Acronyms InCRePaS
- 02 Feb 2010 New source identified and integrated (Netherlands Trial Register record no. NTR449).
- 19 Aug 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials record.
- 08 Nov 2006 New trial record.